Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 5
2006 5
2007 14
2008 12
2009 12
2010 14
2011 18
2012 15
2013 8
2014 7
2015 17
2016 19
2017 17
2018 11
2019 10
2020 5
2021 14
2022 7
2023 6
2024 6
2025 10
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shing miyamoto (8 results)?
Drug review: Pazopanib.
Miyamoto S, Kakutani S, Sato Y, Hanashi A, Kinoshita Y, Ishikawa A. Miyamoto S, et al. Jpn J Clin Oncol. 2018 Jun 1;48(6):503-513. doi: 10.1093/jjco/hyy053. Jpn J Clin Oncol. 2018. PMID: 29684209 Review.
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Kato Y, Udagawa H, Matsumoto S, Izumi H, Ohe Y, Kato T, Nishino K, Miyamoto S, Kawana S, Chikamori K, Shingyoji M, Sato Y, Takada Y, Toyozawa R, Azuma K, Tanaka Y, Sakai T, Shibata Y, Sugiyama E, Nosaki K, Zenke Y, Umemura S, Yoh K, Seike M, Goto K. Kato Y, et al. Among authors: miyamoto s. Lung Cancer. 2024 Nov;197:107992. doi: 10.1016/j.lungcan.2024.107992. Epub 2024 Oct 13. Lung Cancer. 2024. PMID: 39423763
Platinum hypersensitivity and desensitization.
Miyamoto S, Okada R, Ando K. Miyamoto S, et al. Jpn J Clin Oncol. 2015 Sep;45(9):795-804. doi: 10.1093/jjco/hyv081. Epub 2015 Jun 7. Jpn J Clin Oncol. 2015. PMID: 26056327 Review.
Anticancer drugs during pregnancy.
Miyamoto S, Yamada M, Kasai Y, Miyauchi A, Andoh K. Miyamoto S, et al. Jpn J Clin Oncol. 2016 Sep;46(9):795-804. doi: 10.1093/jjco/hyw073. Epub 2016 Jun 9. Jpn J Clin Oncol. 2016. PMID: 27284093 Review.
Contribution of colibactin-producing Escherichia coli to colonic carcinogenesis.
Ishikawa H, Aoki R, Mutoh M, Ishiguro S, Tanaka T, Miyoshi N, Miyamoto S, Hamoya T, Yoshida N, Wakabayashi K, Watanabe K. Ishikawa H, et al. Among authors: miyamoto s. eGastroenterology. 2025 Jun 26;3(2):e100177. doi: 10.1136/egastro-2024-100177. eCollection 2025. eGastroenterology. 2025. PMID: 40589427 Free PMC article. No abstract available.
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid).
Sugimoto A, Matsumoto S, Udagawa H, Itotani R, Usui Y, Umemura S, Nishino K, Nakachi I, Kuyama S, Daga H, Hara S, Miyamoto S, Kato T, Sakakibara-Konishi J, Tabata E, Nakagawa T, Kawaguchi T, Sakai T, Shibata Y, Izumi H, Nosaki K, Zenke Y, Yoh K, Goto K. Sugimoto A, et al. Among authors: miyamoto s. Clin Cancer Res. 2023 Apr 14;29(8):1506-1514. doi: 10.1158/1078-0432.CCR-22-1749. Clin Cancer Res. 2023. PMID: 36201167
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Umemura S, Udagawa H, Ikeda T, Murakami H, Daga H, Toyozawa R, Kozuki T, Sakakibara-Konishi J, Ohe Y, Morise M, Kato T, Shingyoji M, Hara S, Furuya N, Teranishi S, Takata S, Miyamoto S, Nakachi I, Wakabayashi M, Nomura S, Sato A, Ishii G, Tsuchihara K, Sugiyama E, Kirita K, Sakai T, Shibata Y, Izumi H, Nosaki K, Zenke Y, Matsumoto S, Yoh K, Niho S, Goto K. Umemura S, et al. Among authors: miyamoto s. J Thorac Oncol. 2025 Feb;20(2):177-193. doi: 10.1016/j.jtho.2024.10.004. Epub 2024 Oct 10. J Thorac Oncol. 2025. PMID: 39395663 Free article.
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).
Uehara Y, Izumi H, Kobayashi IS, Matsumoto S, Hosomi Y, Okuno T, Sugisaka J, Takase N, Taima K, Sasaki S, Teranishi S, Miyamoto S, Mori M, Nakashima C, Asano S, Oi H, Sakai T, Shibata Y, Udagawa H, Sugiyama E, Nosaki K, Umemura S, Zenke Y, Yoh K, Ikeda S, Costa DB, Kobayashi SS, Goto K. Uehara Y, et al. Among authors: miyamoto s. Lung Cancer. 2025 Apr;202:108479. doi: 10.1016/j.lungcan.2025.108479. Epub 2025 Mar 5. Lung Cancer. 2025. PMID: 40088581 Free PMC article.
Effectiveness of Systemic Corticosteroids in Managing Cancer-Related Neuropathic Pain: A Multicenter Prospective Observational Study.
Tagami K, Kessoku T, Hasuo H, Ishiki H, Yamaguchi T, Mori M, Hiratsuka Y, Kosugi K, Okuda Y, Yamaguchi T, Miyamoto S, Oya K, Nishijima K, Koinuma Y, Morikawa N, Oyamada S, Ariyoshi K, Higuchi M, Mawatari H, Tanaka K, Shimazu M, Kiuchi D, Sato M, Iwaki M, Koike R, Sato K, Inoue A. Tagami K, et al. Among authors: miyamoto s. Cancers (Basel). 2025 May 12;17(10):1630. doi: 10.3390/cancers17101630. Cancers (Basel). 2025. PMID: 40427128 Free PMC article.
220 results